BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 96139)

  • 1. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A; Mantero F; Opocher G; Armanini D; Lechi C; Covi G
    J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the kallikrein-kinin system and vascular reactivity in Bartter's syndrome.
    Rodriguez-Portales JA; Lopez-Moreno JM; Mahana D
    Hypertension; 1985; 7(6 Pt 1):1017-22. PubMed ID: 2416684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of human urinary and plasma kinins to sodium-retaining steroids and plasma renin activity.
    Vinci JM; Zusman RM; Izzo JL; Bowden RE; Horwitz D; Pisano JJ; Keiser HR
    Adv Exp Med Biol; 1979; 120B():503-14. PubMed ID: 229712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
    Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
    Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
    Hornych A
    Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture.
    Wong PY; Talamo RC; Williams GH; Colman RW
    J Clin Invest; 1975 Apr; 55(4):691-8. PubMed ID: 235559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of Bartter's syndrome--special reference to tubular function, the prostaglandin and the kallikrein-kinin system in the kidney].
    Ishiyama N; Kikuchi K; Oimatsu H; Nakao T; Takigami Y; Kondo A; Iimura O; Yamaguchi J
    Nihon Jinzo Gakkai Shi; 1985 Jan; 27(1):113-21. PubMed ID: 3847529
    [No Abstract]   [Full Text] [Related]  

  • 9. On the pathogenetic role of prostaglandins in Bartter's syndrome.
    Nielsen I; Hesse B; Christensen P
    Acta Med Scand Suppl; 1979; 625():135-40. PubMed ID: 285569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kallikrein-kinin system in essential hypertension.
    Keiser HR
    Clin Exp Hypertens (1978); 1980; 2(3-4):675-91. PubMed ID: 7000465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
    Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
    JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
    Gill JR; Frölich JC; Bowden RE; Taylor AA; Keiser HR; Seyberth HW; Oates JA; Bartter FC
    Am J Med; 1976 Jul; 61(1):43-51. PubMed ID: 820194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bartter's syndrome: physiological and pharmacological studies.
    Delaney VB; Oliver JF; Simms M; Costello J; Bourke E
    Q J Med; 1981; 50(198):213-32. PubMed ID: 6171004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostaglandins, kallikrein-kinin and dopamine. Practical implications of this vasodilator-natriuretic system].
    Abenhaim L; Kuchel O
    Union Med Can; 1979 Jun; 108(6):621-39. PubMed ID: 388782
    [No Abstract]   [Full Text] [Related]  

  • 15. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bartter's syndrome results from an imbalance of vasoactive hormones.
    McGiff JC
    Ann Intern Med; 1977 Sep; 87(3):369-72. PubMed ID: 900681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary kallikrein excretion in Bartter's syndrome.
    Lechi A; Covi G; Lechi C; Mantero F; Scuro LA
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1175-8. PubMed ID: 993321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and qualitative estimation of urinary kallikrein in a patient with Bartter's syndrome.
    Yamada K; Watanabe M; Nishikawa T; Mikami K; Shirai K; Tamura Y; Yamamoto M; Kumagai A; Matsuda Y; Moriya H
    Endocrinol Jpn; 1978 Dec; 25(6):583-9. PubMed ID: 751804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endocrinological analysis before and after living-related renal transplantation in a patient of Bartter's syndrome].
    Yokoyama T
    Nihon Jinzo Gakkai Shi; 1995 Oct; 37(10):580-6. PubMed ID: 7474511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.